Yang, Z.; Suda, G.; Maehara, O.; Ohara, M.; Yoda, T.; Sasaki, T.; Kohya, R.; Yoshida, S.; Hosoda, S.; Tokuchi, Y.;
et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers 2023, 15, 593.
https://doi.org/10.3390/cancers15030593
AMA Style
Yang Z, Suda G, Maehara O, Ohara M, Yoda T, Sasaki T, Kohya R, Yoshida S, Hosoda S, Tokuchi Y,
et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023; 15(3):593.
https://doi.org/10.3390/cancers15030593
Chicago/Turabian Style
Yang, Zijian, Goki Suda, Osamu Maehara, Masatsugu Ohara, Tomoka Yoda, Takashi Sasaki, Risako Kohya, Sonoe Yoshida, Shunichi Hosoda, Yoshimasa Tokuchi,
and et al. 2023. "Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma" Cancers 15, no. 3: 593.
https://doi.org/10.3390/cancers15030593
APA Style
Yang, Z., Suda, G., Maehara, O., Ohara, M., Yoda, T., Sasaki, T., Kohya, R., Yoshida, S., Hosoda, S., Tokuchi, Y., Kitagataya, T., Suzuki, K., Kawagishi, N., Nakai, M., Sho, T., Natsuizaka, M., Ogawa, K., Ohnishi, S., & Sakamoto, N.
(2023). Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers, 15(3), 593.
https://doi.org/10.3390/cancers15030593